Prevention of Anemia
Conditions
Brief summary
The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment.
Detailed description
The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment
Interventions
oral treatment
Sponsors
Study design
Eligibility
Inclusion criteria
1. Age more or equal of 18 years 2. Registration consent 3. Have complete 12h week of pregnancy 4. Hemoglobin levels \<10,5 ptl 5. Hematocrit \< 32 %
Exclusion criteria
1. Age \<18 years 2. Absent registration consent 3. Step of pregnancy less than 12 weeks 4. Coadministration formulations iron oral or parenterally 5. Background of liver kirrosis 6. Background of aimosidirosis 7. Background acquired or chronic aimatochromatosis 8. Aplastic , Hemolytic anemia and chronic diseases 9. Chronic pancreatitis 10. Subjective renal or/and liver disease 11. Hypothyroidism or yperthyreoeidismos
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter with questionnaire | up to 24 months | Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| adverse reactions | up to 24 months | adverse reactions |